NCT06202131Recruiting
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Prospective Single-center Study About the Use of Ctdna in the Management of Patients With Tumors of the Gastrointestinal Tract
Source: ClinicalTrials.gov · Last updated 2 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 2 Jan 2024
- Start date
- 1 Nov 2023
- Primary completion date
- 1 Nov 2028
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- NCT number
- NCT06202131
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Nov 2023 to the primary completion date, 1 Nov 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No histological diagnosis of neoplasia of the gastrointestinal tract.
- No written informed consent.
Who the study is looking for
- Age \>18 years
- PS ECOG \<2;
- Histological diagnosis of gastrointestinal cancer: esophageal, gastric, intestinal, pancreatic, biliary tract neoplasms;
- Radiological evidence of resectable/locally advanced/metastatic disease on the date of signing the written informed consent;
- Adequate organ and function;
- Availability of tumor histological material.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Policlinico Agostino Gemelli Coordinator of this site? Confirm its status | Rome | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.